TEAS RF New Application

TIVDAK

SEAGEN INC.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88130645
Filing Date: 09/25/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88130645
MARK INFORMATION
*MARK TIVDAK
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TIVDAK
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Seattle Genetics, Inc.
*STREET 21823 30th Drive S.E.
*CITY Bothell
*STATE
(Required for U.S. applicants)
Washington
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
98021
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME John C. Baum
ATTORNEY DOCKET NUMBER SEATTLE00025
FIRM NAME Owen, Wickersham & Erickson, P.C.
STREET 455 Market Street, Suite 1910
CITY San Francisco
STATE California
COUNTRY United States
ZIP/POSTAL CODE 94105
PHONE 415-882-3200
FAX 415-882-3232
EMAIL ADDRESS tmparalegal@owe.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Melville Owen, Gregory N. Owen, Noel M. Cook, Lawrence G. Townsend, Linda Joy Kattwinkel, Kathleen E. Letourneau, and Spencer F. Owen
CORRESPONDENCE INFORMATION
NAME John C. Baum
FIRM NAME Owen, Wickersham & Erickson, P.C.
STREET 455 Market Street, Suite 1910
CITY San Francisco
STATE California
COUNTRY United States
ZIP/POSTAL CODE 94105
PHONE 415-882-3200
FAX 415-882-3232
*EMAIL ADDRESS tmparalegal@owe.com; jcbaum@owe.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE /John C. Baum/
SIGNATORY'S NAME John C. Baum
SIGNATORY'S POSITION Attorney of record, California bar member
SIGNATORY'S PHONE NUMBER 415-882-3200
DATE SIGNED 09/25/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88130645
Filing Date: 09/25/2018

To the Commissioner for Trademarks:

MARK: TIVDAK (Standard Characters, see mark)
The literal element of the mark consists of TIVDAK.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, Seattle Genetics, Inc., a corporation of Delaware, having an address of
      21823 30th Drive S.E.
      Bothell, Washington 98021
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      John C. Baum and Melville Owen, Gregory N. Owen, Noel M. Cook, Lawrence G. Townsend, Linda Joy Kattwinkel, Kathleen E. Letourneau, and Spencer F. Owen of Owen, Wickersham & Erickson, P.C.      455 Market Street, Suite 1910
      San Francisco, California 94105
      United States
      415-882-3200(phone)
      415-882-3232(fax)
      tmparalegal@owe.com (authorized)
The attorney docket/reference number is SEATTLE00025.
The applicant's current Correspondence Information:
      John C. Baum
      Owen, Wickersham & Erickson, P.C.
      455 Market Street, Suite 1910
      San Francisco, California 94105
      415-882-3200(phone)
      415-882-3232(fax)
      tmparalegal@owe.com;jcbaum@owe.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /John C. Baum/   Date: 09/25/2018
Signatory's Name: John C. Baum
Signatory's Position: Attorney of record, California bar member
Payment Sale Number: 88130645
Payment Accounting Date: 09/25/2018

Serial Number: 88130645
Internet Transmission Date: Tue Sep 25 13:08:40 EDT 2018
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XX-20180925130840710
762-88130645-61059c2b5e5b49286f6f3cc24ea
75fab69bf98031b5fe7475ca3758f88e3bfbe6b8
-DA-11924-20180925130544831002

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed